Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study.

BMJ Open Diabetes Res Care · 2020 · PMC7039575 · PMID 31958303

Europe PMC DOI

hedged sentence

0.0850

closest p · 1.7× alpha

0.0850

boldest claim

The sentences

borderline significancep=0.085so close (0.05 < p ≤ 0.1)

Patients with a high baseline C-peptide level also showed better achievement of target, but with only borderline significance (p=0.085).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.